CRYSFORMA

The Esteve – ICIQ Joint Unit is a collaborative research project between the pharmaceutical company ESTEVE and ICIQ, dedicated to the development of new chemical processes to obtain new scaffolds and building blocks that can generate medicinal chemistry libraries with the aim of identifying new lead compounds.

It involves up to seven post-doctoral researchers and takes advantage of ICIQ group leaders’ assessment and of ICIQ’s state-of-the-art instrumentation facilities.

CRYSFORMA

The Henkel – ICIQ Joint Unit is a collaborative research project between the global market leader in adhesives, sealants and surface treatment Henkel and ICIQ, dedicated to the development of high performance adhesives through novel trigger or cure reactions.

The project is approached both from the experimental and computational viewpoint, it involves nine post-doctoral researchers and receives scientific advice from several ICIQ Group Leaders

Do NOT follow this link or you will be banned from the site!